Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

This transformation, marked by a fresh logo and modernized brand identity ... in T1a Tumors with High-Risk Features and T1b Tumors Castle Biosciences, Inc. , a company improving health through ...

This includes a fresh logo, a simple color palette and graphic shapes that bring ... Director and Alice Inigo-Jones as Development & Strategy Director. Dyer joined the company from Zebra Projects, ...

Berenberg Bank analyst Luisa Hector maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a price ...

Merck & Co., Inc. (MRK) announced the positive results from the Phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, the ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

We recently compiled a list of 10 Most Promising Long-Term Stocks According to Hedge Funds. In this article, we will look at ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

We recently compiled a list of the 8 Best US Stocks For Foreign Investors Right Now. In this article, we are going to take a ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best medical stocks to buy now. The medical and healthcare industry is one of the largest ...

Oakmark Equity and Income Fund highlighted stocks like Merck & Co., Inc. (NYSE:MRK) in the third quarter 2024 investor letter. Merck & Co., Inc. (NYSE:MRK) is a healthcare company that operates ...

On Wednesday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $110.42 which represents a decrease of $-1.11 or -1.00% from the prior close of $111.53. The stock opened at $111 and touched ...